Advertisement
Singapore markets close in 3 hours 41 minutes
  • Straits Times Index

    3,168.28
    -19.38 (-0.61%)
     
  • Nikkei

    37,072.87
    -1,006.83 (-2.64%)
     
  • Hang Seng

    16,199.74
    -186.13 (-1.14%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Bitcoin USD

    62,182.30
    +482.64 (+0.78%)
     
  • CMC Crypto 200

    1,291.49
    +405.95 (+44.83%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,398.20
    +0.20 (+0.01%)
     
  • Crude Oil

    84.48
    +1.75 (+2.12%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • FTSE Bursa Malaysia

    1,551.42
    +6.66 (+0.43%)
     
  • Jakarta Composite Index

    7,063.10
    -103.72 (-1.45%)
     
  • PSE Index

    6,418.42
    -104.77 (-1.61%)
     

Henry Schein Earnings, Revenue Beat in Q4

Henry Schein Earnings, Revenue Beat in Q4
Henry Schein Earnings, Revenue Beat in Q4

Investing.com - Henry Schein reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Henry Schein announced earnings per share of $0.97 on revenue of $2.67B. Analysts polled by Investing.com anticipated EPS of $0.91 on revenue of $2.64B. That with comparison to EPS of $1.12 on revenue of $3.38B in the same period a year before. Henry Schein had reported EPS of $0.9 on revenue of $2.51B in the previous quarter. Analysts are expecting EPS of $0.87 and revenue of $2.48B in the upcoming quarter.

Henry Schein shares are up 10.48% from the beginning of the year , still down 0.32% from its 52 week high of $73.95 set on February 19. They are outperforming the Nasdaq which is up 8.6% year to date.

Henry Schein follows other major Healthcare sector earnings this month

Henry Schein's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.

ADVERTISEMENT

Novartis ADR had beat expectations on January 29 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Domino's beats U.S. same-store sales estimates on delivery, menu boost

Volkswagen to resume talks over German class action on emissions

American Electric Power Earnings inline, Revenue Misses In Q4